High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene

Maria I. Torres-Arzayus, Jaime Font De Mora, Jing Yuan, Francisca Vazquez, Roderick Bronson, Montserrat Rue, William R. Sellers, Myles Brown

Research output: Contribution to journalArticlepeer-review

321 Scopus citations

Abstract

The gene encoding AIB1, an estrogen receptor coactivator, is amplified in a subset of human breast cancers. Here we show that overexpression of AIB1 in transgenic mice (AIB1-tg) leads to mammary hypertrophy, hyperplasia, abnormal postweaning involution, and the development of malignant mammary tumors. Tumors are also increased in other organs, including the pituitary and uterus. AIB1 overexpression increases mammary IGF-I mRNA and serum IGF-I protein levels. In addition, IGF-I receptor and downstream signaling molecules are activated in primary mammary epithelial cells and mammary tumor cells derived from AIB1-tg mice. Knockdown of AIB1 expression in cultured AIB1-tg mammary tumor cells leads to reduced IGF-I mRNA levels and increased apoptosis, suggesting that an autocrine IGF-I loop underlies the mechanism of AIB1-induced oncogenesis.

Original languageEnglish
Pages (from-to)263-274
Number of pages12
JournalCancer Cell
Volume6
Issue number3
DOIs
StatePublished - Sep 2004
Externally publishedYes

Fingerprint

Dive into the research topics of 'High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene'. Together they form a unique fingerprint.

Cite this